Objective To determine whether 123 I can be used as a safe and effective alternative tracer
to 131 I for imaging remnant tissue and for searching for metastatic lesions of well …

Thyroid stunning has been reported as the temporary impairment of thyroid tissue after a
111-MBq or greater diagnostic 131I dose that decreases the final absorbed dose in ablative …

In this study, we compared 99mTcmetho@ yisobu@ ylisonitrile (MIBI) with@
Â1Tlscintigraphy for the detection of residual thyroid cancer not found by 1311scans in …

Recent clinical and experimental data demonstrate that thyroid stunning is caused by
previous irradiation and may influence the efficacy of 131I radiation therapy of thyroid cancer …

In radioiodine therapy for malignant thyroid disease, the pre-therapeutically administered
iodine-131-dose can reduce the potential of thyroid or thyroid carcinoma cells to absorb the …

Background: Role of 131I Whole body scan in thyroid cancer management is well
documented. The limitation and false positive detection in this modality can be overcome …

Purpose The use of I-123 in lieu of I-131 for diagnostic whole-body thyroid tumor scanning
(DxRaI) in patients with differentiated thyroid cancer obviates the risk for stunning and …

Purpose To retrospectively determine the incremental diagnostic value of adding single
photon emission computed tomography/computed tomography (SPECT/CT) to whole-body …

Background: There is a growing belief that a pretherapy scan yields little or no additional
information that would impact on radioiodine ablation dosing. In addition, there is some …

Primary treatment of differentiated thyroid carcinoma consists of total thyroidectomy followed
by ablation of thyroid tissue remnants and possible metastases by means of radioactive …